4. Summary of participant and intervention characteristics.
| Author Year | Participant characteristics | Intervention characteristics | |||||||
| Number allocated (analysed) |
Type of participants |
Time since onset of stroke (mean or median or recruitment timeframe) |
% Men |
Age (mean/median years) |
CR/CA |
Duration (session, weeks) |
Frequency (times per week) |
Total dose (maximum possible hours) |
|
| Akerlund 2013 | 34 (29) | Outpatients | 30/28 weeks (7–8 months) |
NR | IG: 47.38 CG: 52.86 |
CR | 30–45 min 5 weeks |
5 | 18.75 |
| Barker‐Collo 2009 | 78 (78) | Inpatients | 18/19 days | 60 | IG: 70.2 CG: 67.7 |
CR | 60 min 4 weeks |
5 | 20 |
| Bo 2019 | 114 (92) | Outpatients | < 6 months' recruitment | 55 | IG: 67.51 CG: 64.36 |
CR | 60 min 12 weeks |
3 | 36 |
| Carter 1983 | 33 (28a, 25b) | Inpatients | 5 days (from admittance)c | 48 | IG: 70.5 CG: 73.4 |
CR | 30–40 min 3–4 weeks |
3 | 8 |
| Chen 2015 | 80 (80) | Inpatients | ≤ 3 months' recruitment | 65 | 57.74 | CR | 30 min 4 weeks |
5 | 10 |
| Cho 2015 | 25 (25) | Inpatients | 5/6 months | 64 | IG: 60 CG: 63.7 |
CR | 30 min 6 weeks |
5 | 15 |
| Cho 2016 | 30 (30) | Inpatients | 5/6.5 months | 53 | IG: 63 CG:64 |
CR | 30 min 6 weeks |
5 | 15 |
| De Luca 2018 | 35 (35) | Not designated | 3.5 months | 51 | 43.1 | CR | 45 min 8 weeks |
3 | 18 |
| Hasanzadeh Pashang 2020 | 20 (20) | Not designated | 12/20 months | 75 | IG: 53.90 CG: 57.70 | CR | 60 min 8 weeks |
1 | 8 |
| Jiang 2016 | 120 (100) | Inpatients and outpatients | 43/44 days | 49 | IG: 62.37 CG: 60.53 |
CR | 30 min 12 weeks |
5 | 30 |
| Lin 2014 | 34 (34) | Not designated | 228 days (8 months) |
59 | IG: 62.4 CG: 63.2 | CR | 60 min 10 weeks |
6 | 60 |
| Lundqvist 2010 | 13 (13) | Outpatients | 51 months | 54 | 45.2 | CR | 45–60 min 5 weeks |
5 | 25 |
| Maggio 2020 | 40 (40) | Not reported | 6 months | 55 | 53.9 | CA | 60 min 8 weeks |
3 | 24 |
| Park 2015a | 30 (30) | Inpatients | 1.5/1.8 months | 47 | IG: 64.7 CG: 65.2 |
CR | 30 min 4 weeks |
5 | 10 |
| Prokopenko 2013 | 43 (43) | Inpatients | < 2 weeks' recruitment | 53 | IG: 61 CG: 66 |
CR | 30 min 2 weeks |
7 | 7 (up to 15) |
| Prokopenko 2018 | 19 (19) | Not reported | < 6 months' recruitment | 72 | IG: 59.5 CG: 62.55 |
CR | 30–40 min 10 days |
5–7 | 6.7 |
| Prokopenko 2019 | 49 (49) | Not reported | "early and late recovery period" recruitment | 65 | IG: 59 CG: 60.5 |
CR | 30–40 min 10 days |
5–7 | 6.7 |
| Skidmore 2015a | 30 (30) | Inpatients | 16/19 days | 67 | IG: 64.87 CG: 71.80 |
CA | 3.75 hours For duration of inpatient therapy |
1 | ND |
| Skidmore 2017 | 43 (43) | Inpatients | 16/22 days | 51 | IG: 65.86 CG: 66.73 |
CA | 45 min 2 weeks |
5 | 7.5 |
| van de Ven 2017 | 97d (97) | Outpatients | 28/29 months | 69e | IG: 57 CG: 61.2 |
CR | 30 min 12 weeks |
5 | 30 |
| Walker 2012 | 70 (64) | Inpatients | 22/26 days | 41 | IG: 77 CG:81 |
CA | 6 weeks | Not reported | Not reported |
| Yeh 2019 | 30 (30) | Not reported | 48/94 months | 70 | IG: 50.63 CG: 60.21 |
CR | 60 min 12–18 weeks |
2–3 | 36 |
| Yoo 2015 | 46 (46) | Inpatients | 11 months | 37 | IG: 53.2 CG: 56.3 |
CR | 30 min 5 weeks |
5 | 12.5 |
| Zuchella 2014 | 92 (87) | inpatients | < 4 weeks recruitment ("time for admission" 11/11.5 days) |
53 | IG: 64 CG:70 |
CR | 60 min 4 weeks |
4 | 16 |
CA: compensatory‐adaptive; CG: control group; CR: cognitive remediation; IG: intervention group; min; minutes; ND: no data. aFor ADL outcome. bFor time judgement outcome. cThis is reported as number of mean days from admittance to stroke programme, so it is unclear if this is duration since stroke onset. dThis number is for all participants randomised, i.e. to 3 groups, intervention, active control, and waiting‐list control groups; data from either the waiting‐list control or the active control groups were used in analysis. eMean of the percentages for each of the 3 groups.